Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment

Part of paid clinical trials in Aurora, Illinois.

Sponsor
Sonova AG
Study ID
NCT07526428
Status
Terminated

Conditions

  • Hearing Loss

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Phonak Audeo Infinio Hearing Aid — DEVICE
    Phonak Audeo Infinio RIC
  • Competitor Device A — DEVICE
    Competitor Device A

Study Details

The goal of this interventional study is to evaluate the DNN Noise reduction feature of Phonak hearing aids in adults with moderate to moderate severe hearing loss. The main questions it aims to answer are: Do participants correctly identify significantly more words on the AZBio Sentence Test when using Phonak's DNN NR feature than when using Competitor device A in a lab setting? Do participants subjectively rate the speech clarity, ease of listening, and listening confidence higher when using Phonak's DNN feature than when using Competitor device A in both a lab setting and a real-world cafe setting? Do participants have an overall preference for the Phonak device over the Competitor device A in a real-world cafe setting? Participants will be fit with both the Phonak device and a Competitor device A in the lab. They will be given the AZBio Sentence test and repeat as many words as they can in a simulated noisy environment. Following the lab visit, participants will meet in a group with three other conversation partners in a real-world setting and asked to complete subjective questionnaires during the visit.

Key Dates

Start date
Apr 9, 2026
Status verified
May 2026
Primary completion
Apr 19, 2026
Completion
Apr 19, 2026

Study Design

Enrollment
21 participants (actual)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Participants fit and tested with the Phonak device first, then the Competitor device A.
    Participants that are tested first with the Phonak device, and then with the Competitor device A.
  • Experimental: Participants fit and tested with Competitor device A first, then with Phonak device.
    Participants that are tested first with the Competitor device A, then with the Phonak device.

Primary Outcome Measure

AZBio Sentence Test [ Time Frame: Day 1 of study ]

Locations (1)

FacilityCityStateZIPSite coordinators
Phonak Audiology Research CenterAuroraIllinois60504-7940-

Find similar trials in Aurora, IL

By research site
Phonak Audiology Research Center· Aurora, IL

Related Studies